Feed Top Reports Pricing

⌘K

16:06:43·4h

SECFilingvia Quantisnow

SEC Form DEFA14A filed by Immunome Inc.

ByQuantisnow·Wall Street's wire, on your screen.

IMNM· Immunome Inc.

Health Care

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMNM (Immunome Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

IMNM
Immunome Inc.
Health Care

Recent analyst ratings

Feb 12UpdateH.C. Wainwright$40.00
Dec 1UpdateTruist$36.00
Sep 22UpdateGoldman$26.00
Sep 5UpdateCraig Hallum$26.00
Apr 2UpdateLake Street$23.00
Nov 8UpdateStephens$30.00

Related

SEC4h
SEC Form DEF 14A filed by Immunome Inc.
PR3d
Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting
INSIDER21d
SEC Form 4 filed by Higgins Jack
INSIDER21d
SEC Form 4 filed by Rosett Max
PR22d
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
INSIDER23d
SEC Form 4 filed by Higgins Jack
INSIDER24d
SEC Form 4 filed by Siegall Clay B
SEC29d
Amendment: SEC Form SCHEDULE 13G/A filed by Immunome Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022